Hugel, Inc.
A biopharmaceutical company developing and distributing medical aesthetic products.
145020 | KO
Overview
Corporate Details
- ISIN(s):
- KR7145020004
- LEI:
- Country:
- South Korea
- Address:
- 강원특별자치도 춘천시 동내면 거두단지1길 23 -, 춘천시
- Website:
- https://www.hugel-inc.com/
- Sector:
- Manufacturing
Description
Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and distributes a portfolio of high-quality products, including its flagship botulinum toxin type A formulations, known commercially as Botulax and Letybo. Its product line also features a range of hyaluronic acid (HA) fillers and PDO threads. Recognized as a leader in its field, Hugel is focused on providing innovative, efficient, and proven solutions to medical professionals worldwide. The company is committed to advancing aesthetic medicine through continuous research and development to create effective and reliable treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-04-14 00:00 |
주주총회소집공고
|
Korean | 150.5 KB | ||
| 2022-04-11 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 이탈리아 품목허가 획득)
|
Korean | 8.5 KB | ||
| 2022-04-08 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 포르투갈 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-04-07 00:00 |
주요사항보고서(자기주식취득신탁계약체결결정)
|
Korean | 27.8 KB | ||
| 2022-04-04 00:00 |
풍문또는보도에대한해명
|
Korean | 4.5 KB | ||
| 2022-03-30 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 네덜란드 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-03-28 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 아일랜드 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-03-25 00:00 |
정기주주총회결과
|
Korean | 20.3 KB | ||
| 2022-03-25 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 루마니아 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-03-24 00:00 |
투자판단관련주요경영사항(보툴렉스(Botulax, 수출명 Letybo) 50유닛의 영국 품목허가 획득)
|
Korean | 8.6 KB | ||
| 2022-03-18 00:00 |
신탁계약에의한취득상황보고서
|
Korean | 22.7 KB | ||
| 2022-03-17 00:00 |
감사보고서제출
|
Korean | 23.9 KB | ||
| 2022-03-17 00:00 |
사업보고서 (2021.12)
|
Korean | 509.1 KB | ||
| 2022-03-10 00:00 |
주주총회소집공고
|
Korean | 332.5 KB | ||
| 2022-03-10 00:00 |
주주총회집중일개최사유신고
|
Korean | 5.2 KB |
Automate Your Workflow. Get a real-time feed of all Hugel, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Hugel, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Hugel, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
